( ( ( Ortho Streams ) ) )

RTI Biologics and Zimmer Dental Enter Biologics Distribution Agreement

RTI Biologics and Zimmer Dental Enter Distribution Agreement for Global Biologic Implants (RTI)

A look back at the “dark” history of Medtronic’s Infuse on the eve of the Amplify FDA decision

Bone-fusion protein raises questions about doctors’ financial stakes (Milwaukee Journal Sentinel)

Stryker to pay $1.35M penalties for deceptive marketing of OP-1 in Massachusetts

Stryker Settles State OP-1 Complaint (OrthopedicsThisWeek) AG Coakley Announces $1.35 Million Settlement with Stryker Biotech (Mass Attorney General)

Researchers develop better connection between Titanium implants and bone

Better Joint Replacements: Titanium Coating with Protein “Flower Bouquet” Nanoclusters Strengthens Implant Attachment (Georgia Tech) Georgia Tech researchers have developed an improved coating technique that could strengthen the connection between titanium joint-replacement implants and a patient’s own bone by manipulating signals the body’s own cells use to encourage growth.

The FDA stops Regenexx stem cell therapy for orthopedics

FDA Hauls Regenexx Into Court This is a watershed case for stem cells applications in orthopedics. The FDA says that Regenexx is not approved and “no adequate and well-controlled studies have been done to demonstrate its safety or effectiveness for any indication.”

SI-Bone raises $11M to develop fusion of sacroiliac joint

SI-BONE, Inc. Closes $11.0 Million Financing Led by Skyline Ventures

Medtronic acquires Osteotech for $123M (a 1.3x multiple on trailing 12-month revenue)

Medtronic Press Release RTI Press Release Medtronic to Buy Osteotech for $123 Million (WSJ Online)

FDA panel is split on Medtronic’s PMA for Amplify

FDA Panel Splits On Benefits, Risks Of Medtronic Spine Device (WSJournal)

VIDEO: Dr. Kevin Stone talks about the bio-future of joint replacement

VIDEO:   Dr. Kevin Stone talks about the bio-future of joint  replacement (6 min. TED talk) Trends to watch in Orthopedic Surgery

Bio2Tech, a new Boston spinoff biomaterials company, receives $1.1M in funding

Bio2 Technologies Grabs $1.1M (Xconomy)

keep looking »